Back to User profile » Dr Filip Janku

Papers published by Dr Filip Janku:

Clinical Trial Report

A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies

Piha-Paul SA, Dumbrava EE, Nair BC, Xiong W, Xu L, Mostorino R, Subbiah V, Tannir N, Fu S, Naing A, Janku F, Karp DD, Patel S, Daw NC, Hong D, Meric-Bernstam F, Zinner R

OncoTargets and Therapy 2021, 14:3037-3049

Published Date: 7 May 2021

Review

Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives

Bupathi M, Kaseb A, Janku F

OncoTargets and Therapy 2014, 7:1927-1932

Published Date: 20 October 2014